Document:

Exhibit 4.16

 

Execution
Version

 

“CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS
DOCUMENT HAVE BEEN OMITTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS,
WHICH ARE IDENTIFIED BY ***.”

 

genetic technologies

Limited

 

LICENSE AGREEMENT AND RELEASE

 

Effective as of June 29, 2007 (“EFFECTIVE DATE”), GENETIC TECHNOLOGIES LIMITED, having an office at 60 Hanover
Street, Fitzroy, Victoria 3065, Australia (“GTG”), and THERMO
FISHER SCIENTIFIC INC., having an office at 81 Wyman Street,
Waltham, MA, 02454-9045, USA (“THERMO”), agree as follows:

 

ARTICLE I

BACKGROUND

 

1.1                               GTG represents that it
has certain proprietary and intellectual property rights pertaining to methods
and processes used to extract gene discovery and diagnostic utility from the
non-coding region of genomes.

 

1.2                               THERMO wishes to acquire
a license under, and to obtain access to GTG’s non-coding patents.

 

1.3                               GTG is prepared to grant
a non-exclusive license to THERMO under its non-coding patents, subject to the
terms and conditions of this AGREEMENT.

 

ARTICLE II

GENERAL DEFINITIONS AND RELATIONSHIPS AMONG
DEFINITIONS

 

2.1                               “AGREEMENT” means this
document, its attachments, all addend schedules, exhibits, appendices, and any
amendments to the foregoing.

 

2.2                               “CONFIDENTIAL
INFORMATION” means any and all information which is disclosed by either party
to the other verbally, electronically, visually, or in a written or other
tangible form which is either identified or should be reasonably
understood to be confidential or proprietary. CONFIDENTIAL INFORMATION
includes, but is not limited to, the specific terms and/or conditions of this
AGREEMENT, trade secrets, ideas, processes, formulas, programs, software, source
of supply, technology, discoveries, developments, inventions, techniques,
marketing plans, strategies, forecasts, unpublished financial statements,
prices, costs, and customer lists.

 

2.3                               “FIELD OF USE” means
gene-based, human genetic research and human diagnostics, but excluding certain
genetic testing that is proprietary Myriad Genetics, Inc. and known as
BRACAnalysis®, COLARISSM, COLARIS APSM
, MELARISSM, and CardiaRisk®.

 

 

2.4                               GTG and THERMO may sometimes
hereinafter be collectively referred to as the “parties” and, individually as a
“party” (as required by the context),

 

2.5                               “LICENSED PATENT(S)”
means the United States Patents listed in Appendix “A” attached to this
AGREEMENT and all reissues, reexaminations, divisionals, continuations
continuations-in-part, substitutions, and extensions of the foregoing,
applications therefor, and patents which may issue upon such applications.

 

2.6                               “LICENSED PRODUCT(S)”
means:

 

2.6.1                        products manufactured by THERMO
or on behalf of THERMO of its own design; and

 

2.6.2                        activities and diagnostic
services performed by THERMO;

 

2.6.3                        that but for the license
granted herein would infringe or contribute to the infringement of one or more
claims of a LICENSED PATENT.

 

2.7                               “THERMO” means Thermo
Fisher Scientific Inc. and its wholly owned subsidiaries existing as of the
EFFECTIVE DATE.

 

2.8                               The words “hereof,” “herein”
and “hereunder” and words of similar import when used in this AGREEMENT will
refer to this AGREEMENT as a whole and not to any particular provision of this
AGREEMENT and Article, Section and Subsection references are to this
AGREEMENT unless otherwise specified. Whenever the words “include,” “include?
or “including” are used in this AGREEMENT, they will be deemed to be followed
by the words “without limitation.” The meanings given to terms defined herein
will be equally applicable to both the singular and plural forms of such terms.

 

ARTICLE III

RELEASE

 

3.1                               Subject to the terms and
conditions of this AGREEMENT, GTG agrees that, providing THERMO fully and
faithfully discharges all obligations undertaken by THERMO in this AGREEMENT,
namely, the confidentiality obligations and the obligation to pay the license
issue fee, GTG will release THERMO from all claims, demands, and rights of
action which GTG may have as of the EFFECTIVE DATE on account of
infringement of any LICENSED PATENT prior to the EFFECTIVE DATE to the extent
the acts constituting such infringement would be licensed hereunder.

 

ARTICLE IV

GRANT TO THERMO

 

4.1                               Subject to the terms and
conditions of this AGREEMENT, GTG hereby grants and agrees to grant to THERMO a
worldwide, nonexclusive, non-transferable, perpetual, irrevocable, paid-up
license under the LICENSED PATENTS (without the right to sublicense) to make,
use, sell, offer for sale, and import LICENSED PRODUCTS in the 

 

2

 

FIELD OF USE.
The rights granted herein shall pass through to end-users solely to the extent
required for internal use of LICENSED PRODUCTS by such end-users.

 

4.2                               The rights and licenses
granted by GTG in this AGREEMENT are personal to THERMO. THERMO shall not
assign or otherwise transfer any license or right granted hereunder or any
interest therein without the prior written consent of GTG (which may be
withheld in GTG’s sole and absolute discretion), except to a purchaser of all
or substantially all of the business of THERMO or any of its wholly owned
subsidiaries, to which this AGREEMENT relates, whether by merger, sale of
stock, sale of assets or otherwise; provided, however that prior to the
transfer of ownership such purchaser must expressly assume in writing the
obligations of THERMO or one of its subsidiaries, as the case may be,
under this AGREEMENT and expressly acknowledges in writing that products and/or
services of such purchaser existing prior to the transfer of ownership shall
not be LICENSED PRODUCTS.

 

4.3                               All rights not
explicitly granted to THERMO are reserved by GTG. Not limiting the foregoing,
THERMO acknowledges that it is not granted any rights to any other patents or
other intellectual property rights of GTG or any third party.

 

ARTICLE V

CONSIDERATION

 

5.1                               As consideration for the
licenses and rights granted by this AGREEMENT, THERMO agrees to pay to GTG a
one-time, nonrefundable license issue fee of *** in cash on the EFFECTIVE DATE.

 

5.2                               ***

 

5.3                               All payments by THERMO
to GTG shall be sent by electronic wire transfer to:

 

Key Bank

#307070267

1130 Haxton Drive

Fort Collins, Colorado 80525 

Account: Genetic Technologies Limited 

Account Number: 76009 000 2576

 

5.4                               All fees payable
hereunder by THERMO shall be made in United States Dollars (USD) and are
payable to GTG’s successors, heirs, or assigns, as appropriate.

 

ARTICLE VI

WAIVER

 

6.1                               No waiver by either
party, express or implied, of any breach of any term, condition, or obligation
of this AGREEMENT by the other party shall be construed as a waiver of any
subsequent breach of that term, condition, or obligation, or of any other term,
condition, or obligation of this AGREEMENT of the same or different nature.

 

3

 

ARTICLE VII

CONFIDENTIALITY, PUBLICITY AND PRESS RELEASES

 

7.1                                 LIMITATIONS ON USE AND
DISCLOSURE: The parties agree that the terms and conditions set forth in this
AGREEMENT are CONFIDENTIAL INFORMATION, The CONFIDENTIAL INFORMATION disclosed
by either party (“DISCLOSING PARTY”) to the other party (“RECEIVING PARTY”)
constitutes the confidential and proprietary information of the DISCLOSING
PARTY and the RECEIVING PARTY agrees to treat all CONFIDENTIAL INFORMATION of
the other in the same manner as it treats its own similar proprietary
information, but in no case will the degree of care be less than reasonable
care. The RECEIVING PARTY shall use CONFIDENTIAL INFORMATION of the DISCLOSING
PARTY only in performing under this AGREEMENT and shall retain the CONFIDENTIAL
INFORMATION in confidence and not disclose to any third party (except as
authorized under this AGREEMENT) without the DISCLOSING PARTY’s express written
consent. The RECEIVING PARTY shall disclose the DISCLOSING PARTY’s CONFIDENTIAL
INFORMATION only to those employees and contractors of the RECEIVING PARTY who
have a need to know such information for the purposes of this AGREEMENT, and
such employees and contractors must have entered into agreements with the
RECEIVING PARTY containing confidentiality provisions covering the CONFIDENTIAL
INFORMATION, with terms and conditions at least as restrictive as those set
forth herein. Notwithstanding the foregoing, each party’s confidentiality
obligations hereunder shall not apply to information which as evidenced by
written records:

 

7.1.1                      is already known to the RECEIVING
PARTY without an obligation of confidentiality prior to disclosure by the
DISCLOSING PARTY;

 

7.1.2                      is or becomes publicly available
without fault of the RECEIVING PARTY;

 

7.1.3                      is rightfully obtained by the
RECEIVING PARTY from a third party without restriction as to disclosure, or is
approved for release by written authorization of the DISCLOSING PARTY;

 

7.1.4                      is developed independently by the
RECEIVING PARTY without use of or access to the DISCLOSING PARTY’s CONFIDENTIAL
INFORMATION.

 

7.2                                 PERMITTED USE AND
DISCLOSURE: Each party hereto is permitted to disclose this AGREEMENT and use
or disclose the CONFIDENTIAL INFORMATION disclosed to it by the other party:

 

7.2.1                      To the extent such use or
disclosure is reasonably necessary in connection with complying with stock
exchange rules.

 

7.2.2                      To its legal and/or financial
advisors, provided such advisors maintain the confidentiality of this AGREEMENT.

 

4

 

7.2.3                      To the extent such use or
disclosure is reasonably necessary to enforce its rights under this AGREEMENT
in connection with a legal proceeding or as required to be disclosed by law or
governmental regulation,

 

7.2.4                      To the extent such use or
disclosure is reasonably necessary in connection with prosecuting or defending
litigation, complying with applicable law, court order, submitting information
to tax or other governmental authorities, or otherwise exercising its rights
hereunder.

 

7.2.5                      In the instances set forth in
Sections 7.2.1 or 1.2.4, the RECEIVING PARTY shall provide reasonable advance
written notice to DISCLOSING PARTY of such disclosure and reasonably cooperate
with the DISCLOSING PARTY in limiting such disclosure.

 

7.3                                 PUBLICITY AND PRESS
RELEASES: The parties shall mutually agree upon and jointly issue one or more
appropriate media/press releases with regard to the existence of this AGREEMENT
within seven (7) days of the EFFECTIVE DATE or as soon as reasonably
practical thereafter. Neither party shall issue any other press releases
relating to this AGREEMENT without prior written approval of the other party;
provided however, that:

 

7.3.1                      Each party shall be permitted to
post a copy of, provide a link on its web site to or otherwise summarize any
permitted disclosures made under this AGREEMENT;

 

7.3.2                      GTG shall be able to disclose to
other licensees and/or prospective licensees the identity of THERMO and the
existence of this AGREEMENT; and

 

7.3.3                      THERMO shall be able to disclose
to customers and/or prospective customers the identity of GTG and the existence
of this AGREEMENT.

 

ARTICLE VIII

NOTICE

 

8.1                                 Any notice, request or
statement hereunder shall be deemed to be sufficiently given or rendered when
personally delivered, delivered by a major commercial rapid delivery courier
service or mailed by certified or registered mail, return receipt requested,
and if given or rendered to THERMO, addressed to:

 

Peter Y. Lee, Esq.

Director Intellectual Property 

81 Wyman Street 

Post Office Box 9046 

Waltham, MA

02454-9046 

USA

 

5

 

or, if given or rendered to GTG, addressed to:

 

Dr. Melvyn
Jacobson 

Chief Executive Officer 

Genetic Technologies Limited 

60 Hanover Street 

Fitzroy, Victoria 3065 

Australia Ph: +61 419 657 915 

Fax: +1 (970) 484-6698

 

with a copy to;

 

Michael A.
DeSanctis, Esq. 

Hamilton, DeSanctis & Cha, LLP 

225 Union Blvd., Ste. 305 

Lakewood, CO 80228 

USA 

Ph: +1 (303) 284-5103 

Fax: +1 (303) 362-0575

 

or, in any case, to such changed address or person as such parties
shall have specified to each other by written notice.

 

ARTICLE IX

REPRESENTATIONS AND WARRANTIES

 

9.1                               GTG represents and
warrants that it has the full right, power, and authority to enter into and perform its
obligations under this AGREEMENT and grant to THERMO the license and other
rights as set forth herein, and there are no outstanding agreements, grants,
licenses, encumbrances, liens, or agreements, either written or implied,
inconsistent therewith or pursuant to which this AGREEMENT or the parties’
performance hereunder would violate, breach, or cause a default.

 

9.2                               GTG represents and
warrants that the execution, delivery, and performance of this AGREEMENT have
been duly authorized by all necessary corporate actions on the part of
GTG.

 

9.3                               THERMO represents and
warrants that it has the full right, power, and authority to enter into and perform its
obligations under this AGREEMENT, and there are no outstanding agreements,
grants, licenses, encumbrances, liens, or agreements, either written or
implied, inconsistent therewith or pursuant to which this AGREEMENT or the
parties’ performance hereunder would violate, breach, or cause a default.

 

9.4                               THERMO represents and warrants
that the execution, delivery, and performance of this AGREEMENT have been duly
authorized by all necessary corporate actions on the part of THERMO.

 

6

 

9.5                               INDEMNIFICATION:

 

9.5.1                      BY THERMO: THERMO agrees to hold
GTG harmless from any claims by third parties arising from the manufacture,
use, sale, importation, or other disposition of LICENSED PRODUCTS. THERMO shall
indemnify, hold harmless, and defend GTG, and GTG’s subsidiaries, affiliates,
officers, directors, representatives, employees, or agents against any and all
claims, causes of action, demands, judgments, settlements, expenses, or losses
including, but not limited to, reasonable attorneys’ fees and court costs
arising out of or in connection with the design, development, manufacture, use,
sale, packaging, distribution, or shipment of LICENSED PRODUCTS.

 

9.5.2                      BY GTG: GTG shall indemnify, hold
harmless, and defend THERMO, officers, directors, representatives, employees,
or agents against any and all claims, causes of action, demands, judgments,
settlements, expenses, or losses including, but not limited to, reasonable
attorneys’ fees and court costs arising out of or in connection with: (i) any
breach by GTG of any representation, warranty, or covenant hereunder, or (ii) the
failure of GTG to perform any covenants or obligations contained in this
AGREEMENT.

 

9.5.3                      The indemnifying party’s
indemnification obligations under this Section 9.5 are conditioned upon
the indemnified party (i) giving prompt notice of the claim to the
indemnifying party; (ii) granting sole control of the defense or
settlement of the claim or action to the indemnifying party; and (iii) providing
reasonable cooperation to the indemnifying party and, at the indemnifying party’s
request and expense, assistance in the defense or settlement of the claim.

 

9.6                               DISCLAIMER OF
WARRANTIES:

 

9.6.1                      EXCEPT AS EXPRESSLY SET FORTH
HEREIN, EACH PARTY EXPRESSLY DISCLAIMS, TO THE EXTENT ALLOWED BY APPLICABLE
LAW, ANY AND ALL WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING WITHOUT
LIMITATION THE WARRANTIES OF DESIGN, MERCHANTABILITY, FITNESS FOR A PARTICULAR
PURPOSE (EVEN IF INFORMED OF SUCH PURPOSE), NONINFRINGEMENT OF THE INTELLECTUAL
PROPERTY RIGHTS OF THIRD PARTIES, OR ARISING FROM A COURSE OF DEALING, USAGE OR
TRADE PRACTICES, IN ALL CASES WITH RESPECT THERETO.

 

9.6.2                      EXCEPT AS EXPRESSLY SET FORTH
HEREIN, THERMO AGREES THAT THE LICENSED PATENTS ARE PROVIDED “AS IS,” AND THAT
GTG MAKES NO REPRESENTATION OR WARRANTY WITH RESPECT TO THE PERFORMANCE OR SALE
OF LICENSED PRODUCTS INCLUDING THEIR SAFETY, EFFECTIVENESS, OR COMMERCIAL
VIABILITY. NOTWITHSTANDING ANY OTHER PROVISION OF THIS AGREEMENT, GTG
ADDITIONALLY DISCLAIMS ALL OBLIGATIONS AND LIABILITIES FOR DAMAGES WHICH ARISE
OUT OF OR RESULT FROM 

 

7

 

THE PERFORMANCE OR SALE OF LICENSED PRODUCTS. THERMO ASSUMES ALL
RESPONSIBILITY AND LIABILITY FOR LOSS OR DAMAGE CAUSED BY PERFORMANCE OR SALE
OF LICENSED PRODUCTS.

 

9.7                                 LIMITATION OF
LIABILITY: NEITHER PARTY SHALL BE ENTITLED TO RECOVER FROM THE OTHER PARTY ANY
SPECIAL, INCIDENTAL, CONSEQUENTIAL OR PUNITIVE DAMAGES IN CONNECTION WITH THIS
AGREEMENT OR ANY LICENSE GRANTED HEREUNDER. GTG SHALL NOT BE LIABLE FOR ANY
AMOUNTS IN EXCESS OF THE TOTAL AMOUNTS PAID TO GTG BY THERMO HEREUNDER DURING
THE TWELVE (12) MONTHS IMMEDIATELY PRECEDING THE EVENT GIVING RISE TO SUCH
LIABILITY.

 

9.8                                 Nothing contained in
this AGREEMENT shall be construed as:

 

9.8.1                      a warranty or representation by
GTG as to the validity or scope of any LICENSED PATENT; or

 

9.8.2                      a warranty or representation that
any manufacture, sale, lease, use or other disposition hereunder will be free
from infringement of patents other than those under which and to the extent to
which licenses are in force hereunder; or

 

9.8.3                      an agreement to bring or
prosecute actions or suits against third parties for infringement or conferring
any right to bring or prosecute actions or suits against third parties for
infringement; or

 

9.8.4                      conferring any right to use by
either party, in advertising, publicity, or otherwise, any trademark, trade
name or name, or any contraction, abbreviation or simulation thereof, of the
other party; or

 

9.8.5                      conferring by implication,
estoppel or otherwise, upon THERMO, any license or other right under any
intellectual property or patent, except that expressly granted hereunder.

 

ARTICLE X

MISCELLANEOUS

 

10.1                           CONSTRUCTION: This AGREEMENT
has been negotiated by the parties and their respective counsel. This AGREEMENT
shall be interpreted fairly in accordance with its terms and without any strict
construction in favor of or against either party. This AGREEMENT shall not be
construed in fervor or against either party by reason of the authorship of any
provisions hereof. The existence or absence of any term or condition of this
AGREEMENT shall not be used in the construction or interpretation of any other
agreement between the parties. The existence or absence of any term or
condition of any other agreement between the parties shall not be used in the
construction or interpretation of this AGREEMENT.

 

8

 

10.2                         MODIFICATION: This AGREEMENT
sets forth the entire agreement and understanding between the parties as to the
subject matter of this AGREEMENT and merges all prior discussions between the
parties, and no one of the parties shall be bound by any modification of this
AGREEMENT, or by any conditions, definitions, warranties, or representations
with respect to the subject matter of this AGREEMENT, other than as expressly
provided for herein, or as duly set forth on or subsequent to the EFFECTIVE
DATE in writing and signed by duly authorized representatives of the party to
be bound thereby.

 

10.3                         CHOICE OF LAW: This AGREEMENT
and matters connected with the performance thereof shall be construed,
interpreted, applied and governed in all respects in accordance with the laws
of the State of Colorado (excluding conflicts of laws) and of the United
States.

 

10.4                         FORUM SELECTION: The exclusive
venue for any controversy or claim arising out of or in connection with this
AGREEMENT shall be Denver County, Colorado and the parties hereto submit and
consent to jurisdiction and venue in Denver County, Colorado, except to the
extent preempted by federal jurisdiction in which case such jurisdiction shall
be in the Federal courts of Colorado.

 

10.5                         INDEPENDENT BUSINESS: The
parties acknowledge that their business operations are completely independent
and neither party shall at any time hold itself out as an agent or
representative of the other party. No partnership, joint venture, or other
relationship shall be deemed to exist by virtue of this AGREEMENT.

 

10.6                         INDEPENDENT TERMS: All the
terms of this AGREEMENT shall be independent and unconditional so that the performance
of any one term shall not be subject to any set off or counterclaim.

 

10.7                         SEVERABILITY: In the event any
clause or term of this AGREEMENT is determined to be void, invalid, or
unenforceable, the clause shall be reformed to the extent necessary in order to
overcome the limitation and as revised this AGREEMENT shall remain in full
force and effect.

 

10.8                         HEADINGS: The headings
contained within this AGREEMENT are for convenience and reference purposes
only. They do not form a part hereof and shall not affect the meaning
or interpretation of this AGREEMENT.

 

10.9                         FURTHER ASSURANCES: The
parties hereto shall execute such further documents and perform such
further acts as may be necessary to comply with the terms of this
AGREEMENT and consummate the transactions herein provided.

 

10.10                   FORCE MAJEURE: Neither party shall
be held responsible if the fulfillment of any terms or provisions of this
AGREEMENT are delayed or prevented by wars, revolutions, fires, floods, acts of
God, acts of terrorism whether actual or threatened, or other causes similar to
those enumerated and not within the control of the party whose performance is
interfered with, and which by the exercise of reasonable diligence, the party
is unable to prevent.

 

9

 

10.11                 COUNTERPARTS: This AGREEMENT may be
executed in counterparts (and evidenced by facsimile signatures), each of which
will be deemed an original and all of which together constitute one instrument,

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK — SIGNATURE PAGE FOLLOWS]

 

10

 

IN WITNESS WHEREOF, the parties hereto have caused their authorized
representatives to execute this AGREEMENT,

 

	
  GTG:

  	
  THERMO:

  
	
   

  	
   

  
	
  GENETIC
  TECHNOLOGIES LIMITED

  	
  THERMO FISHER
  SCIENTIFIC INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
  By

  	
   

  	
   

  	
  By

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Printed Name
  / Date

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Title

  	
  Title

  
								

 

11

 

IN WITNESS WHEREOF, the parties hereto have caused their authorized
representatives to execute this AGREEMENT,

 

	
  GTG:

  	
  THERMO:

  
	
   

  	
   

  
	
  GENETIC
  TECHNOLOGIES LIMITED

  	
  THERMO
  FISHER SCIENTIFIC INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
  By

  	
   

  	
   

  	
  By

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Printed Name
  / Date

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Title

  	
  Title

  
								

 

12

 

APPENDIX “A”

LICENSED PATENTS

 

	
  US Patent No.

  	
   

  	
  Earliest Priority 

  Date

  	
   

  	
  Filing Date

  	
   

  	
  Issue Date

  	
   

  	
  Expiration Date

  	
   

  
	
  5,612,179

  	
   

  	
  8/25/1989

  	
   

  	
  9/23/1992

  	
   

  	
  3/18/1997

  	
   

  	
  3/9/2010

  	
   

  
	
  5,789,568

  	
   

  	
  8/25/1989

  	
   

  	
  7/16/1996

  	
   

  	
  8/04/1998

  	
   

  	
  8/25/2009

  	
   

  
	
  5192,659

  	
   

  	
  8/25/1989

  	
   

  	
  7/11/1990

  	
   

  	
  3/09/1993

  	
   

  	
  3/09/2010

  	
   

  
	
  5,851,762

  	
   

  	
  7/11/1990

  	
   

  	
  8/22/1994

  	
   

  	
  12/22/1998

  	
   

  	
  12/22/2015

  	
   

  

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

13Exhibit 4.17

 

“CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS
DOCUMENT HAVE BEEN OMITTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS,
WHICH ARE IDENTIFIED BY ***.”

 

LICENSE AGREEMENT

 

Effective as of August 22,
2007 (“EFFECTIVE DATE”), GENETIC TECHNOLOGIES
LIMITED, having an office at 60 Hanover Street, Fitzroy, Victoria
3065, Australia (“GTG”) and MONSANTO COMPANY, having an office at 800 North
Lindbergh Boulevard, St. Louis, Missouri 63141-7843, USA (“LICENSEE”), agree as
follows:

 

WHEREAS, GTG is the owner of
record of various intellectual property rights involving non-coding DNA
technology;

 

WHEREAS, the parties are now
entering into this License Agreement and settlement to resolve certain
remaining potential claims and/or issues between them related to Licensed
Patents;

 

NOW, THEREFORE, in
consideration of the mutual agreements, representations and releases set forth
herein, the parties hereby agree as follows:

 

ARTICLE I

GENERAL DEFINITIONS AND RELATIONSHIPS AMONG DEFINITIONS

 

1.1                               “AGREEMENT”
means this document, its attachments, all addenda, schedules, exhibits,
appendices, and any amendments to the foregoing.

 

1.2                               “CONFIDENTIAL
INFORMATION” means any and all information which is disclosed by either party
to the other verbally, electronically, visually, or in a written or other
tangible form which is either identified or should be reasonably
understood to be confidential or proprietary. CONFIDENTIAL INFORMATION
includes, but is not limited to, the specific terms and/or conditions of this
AGREEMENT, trade secrets, ideas, processes, formulas, programs, software,
source of supply, technology, discoveries, developments, inventions,
techniques, marketing plans, strategies, forecasts, unpublished financial
statements, prices, costs, and customer lists.

 

1.3                               “FIELD OF USE”
means genetic testing, analysis and mapping of swine.

 

1.4                               GTG and
LICENSEE may sometimes hereinafter be collectively referred to as the “parties”
and, individually as a “party” (as required by the context).

 

1.5                               “LICENSED
PATENT(S)” means the United States Patents listed in Appendix “A” attached to
this AGREEMENT and all reissues, reexaminations, divisionals, continuations,
continuations-in-part, substitutions, any patent application claiming priority
to any LICENSED PATENTS and extensions of the foregoing, applications therefor,
and patents which may issue upon such applications, and foreign
counterparts of the foregoing.

 

CONFIDENTIAL

 

1

 

1.6                               “LICENSED
PRODUCT(S)” means:

 

1.6.1                      products
manufactured by LICENSEE or a SUBSIDIARY of LICENSEE, that but for the license
granted herein, would infringe or contribute to or induce the infringement of one
or more valid claims of a LICENSED PATENT; and

 

1.6.2                      services or
methods performed by LICENSEE or a SUBSIDIARY of LICENSEE that, but for the
license granted herein, would infringe or contribute to or induce the
infringement of one or more valid claims of a LICENSED PATENT.

 

1.7                               “SUBSIDIARY”
means any corporation, company or other legal entity, in which more than fifty
percent (50%) of the shares entitled to vote for the election of directors or
persons performing similar functions are, now or hereafter, owned or
controlled, directly or indirectly by a party hereto, or jointly by the parties
hereto; provided, however, that any corporation, company or other legal entity
shall be a SUBSIDIARY only for as long as such ownership or control exists.

 

1.8                               “TERRITORY”
means world-wide.

 

1.9                               The words “hereof,”
“herein” and “hereunder” and words of similar import when used in this
AGREEMENT will refer to this AGREEMENT as a whole and not to any particular
provision of this AGREEMENT and Article, Section and Subsection references
are to this AGREEMENT unless otherwise specified. Whenever the words “include,”
“includes” or “including” are used in this AGREEMENT, they will be deemed to be
followed by the words “without limitation,” The meanings given to terms defined
herein will be equally applicable to both the singular and plural forms of such
terms.

 

ARTICLE II

GRANT TO LICENSEE

 

2.1                               GTG hereby
grants and agrees to grant to LICENSEE, LICENSEE’s SUBSIDIARIES, and their
customers of genetics and/or transgenic products, but only for the use of those
products, during the TERM (as defined below), a nonexclusive, perpetual,
irrevocable, paid-up license under the LICENSED PATENTS to make, have made,
use, sell, offer for sale, and import LICENSED PRODUCTS in the FIELD OF USE throughout
the TERRITORY.

 

2.2                               The rights and
licenses granted by GTG in this AGREEMENT are assignable by LICENSEE to a
purchaser of all or substantially all of the business of LICENSEE to which this
AGREEMENT relates, whether by merger, sale of stock, sale of assets or
otherwise. GTG agrees that products and/or services of such purchaser that are
within the FIELD OF USE shall be LICENSED PRODUCTS following the assignment of
LICENSEE’s rights and licenses under this AGREEMENT to such purchaser.

 

2.3                               All rights not
explicitly granted to LICENSEE and LICENSEE’s SUBSIDIARIES are reserved by GTG.
Not limiting the foregoing, LICENSEE acknowledges that it is not granted any
rights outside of the FIELD OF USE or to any other patents or other 

 

2

 

intellectual property rights
of GTG or any third party by this AGREEMENT except as may be agreed by the
Parties.

 

2.4                               LICENSEE shall
be responsible for all acts and omissions of LICENSEE’s SUBSIDIARIES related to
the rights granted to LICENSEE’s SUBSIDIARIES under this AGREEMENT and LICENSEE
shall ensure that LICENSEE’s SUBSIDIARIES are in compliance with the terms and
conditions of this AGREEMENT at all times.

 

ARTICLE III

CONSIDERATION

 

3.1                               LICENSEE agrees
to pay to GTG a one-time, nonrefundable license issue fee of *** United Stated
Dollars (***) in cash within seven (7) calendar days of the execution of
this AGREEMENT by the Parties.

 

3.2                               ***

 

3.3                               The payment to
GTG of the agreed upon compensation provided for in this AGREEMENT shall be
free of and made without deduction of any taxes, charges, imposts, tariffs,
duties, remittance fees and/or other assessments, including, without limitation
all sales, use, goods, VAT, transfer, customs, stamp duty, excise, withholding,
personal property and other applicable taxes and charges of any kind (“TAXES”),
whether levied by federal, state, or municipal governments in the TERRITORY, or
by other authorities, except for such income tax which may be expressly
required by the laws of the governments in the TERRITORY to be paid for the
account of GTG. The payment of any such income taxes levied upon or withheld
from royalties, fees, compensations, or other payments due to GTG, and the
filing of any information or tax returns with respect thereto, shall be the
responsibility of and shall be borne by LICENSEE. GTG will cooperate to help
LICENSEE minimize, in any lawful manner, the foregoing TAXES and will provide
LICENSEE with reasonable assistance to enable LICENSEE to recover such TAXES as
permitted by law.

 

3.4                               All payments by
LICENSEE to GTG shall be sent by electronic wire transfer to:

 

St. George Bank Limited

333 Collins Street, Melbourne

Victoria, 3000 Australia

Bank State Branch Number: 333.030

SWIFT Code: SGBLAU2SMEL

Account Name: Genetic Technologies Limited

Account Number: 700390978

 

3.5                               GTG releases
LICENSEE and all purchasers and users of LICENSED PRODUCTS acquired from
LICENSEE from all claims, demands and rights of action which GTG may have
as of the EFFECTIVE DATE on account of infringement of any LICENSED PATENTS
prior to the EFFECTIVE DATE to the extent the acts constituting such
infringement would be licensed hereunder.

 

3

 

3.6                               GTG further
releases LICENSEE and its SUBSIDIARIES from all claims, demands and rights of
action which GTG may have as of the EFFECTIVE DATE on account of use of in
licensed products from a third party to the extent such acts would constitute
infringement of any LICENSED PATENT and would be licensed.

 

ARTICLE IV

WAIVER

 

4.1                               No waiver by
either party, express or implied, of any breach of any term, condition, or
obligation of this AGREEMENT by the other party shall be construed as a waiver
of any subsequent breach of that term, condition, or obligation, or of any other
term, condition, or obligation of this AGREEMENT of the same or different
nature.

 

ARTICLE V

TERM

 

5.1                               This AGREEMENT
shall commence on the EFFECTIVE DATE and shall remain in effect on a
country-by-country basis until the last to expire of the LICENSED PATENTS (“TERM”).

 

5.2                               Any alleged
breach of the terms of this AGREEMENT shall be governed by Article 9.6
herein.

 

ARTICLE VI

CONFIDENTIALITY, PUBLICITY AND PRESS RELEASES

 

6.1                               LIMITATIONS ON
USE AND DISCLOSURE: The parties agree that the terms and conditions set forth
in this AGREEMENT are CONFIDENTIAL INFORMATION. The CONFIDENTIAL INFORMATION
disclosed by either party (“DISCLOSING PARTY”) to the other party (“RECEIVING
PARTY”) constitutes the confidential and proprietary information of the
DISCLOSING PARTY and the RECEIVING PARTY agrees to treat all CONFIDENTIAL
INFORMATION of the other in the same manner as it treats its own similar
proprietary information, but in no case will the degree of care be less than
reasonable care.” The RECEIVING PARTY shall use
CONFIDENTIAL INFORMATION of the DISCLOSING PARTY only in performing under this
AGREEMENT and shall retain the CONFIDENTIAL INFORMATION in confidence and not
disclose to any third party (except as authorized under this AGREEMENT) without
the DISCLOSING PARTY’s express written consent. The RECEIVING PARTY shall
disclose the DISCLOSING PARTY’s CONFIDENTIAL INFORMATION only to those
employees and contractors of the RECEIVING PARTY who have a need to know such
information for the purposes of this AGREEMENT, and such employees and
contractors must have entered into agreements with the RECEIVING PARTY
containing confidentiality provisions covering the CONFIDENTIAL INFORMATION,
with terms and conditions at least as restrictive as those set forth herein. Notwithstanding
the foregoing, each party’s confidentiality obligations hereunder shall not
apply to information which as evidenced by written records:

 

4

 

6.1.1                      is already
known to the RECEIVING PARTY without an obligation of confidentiality prior to
disclosure by the DISCLOSING PARTY;

 

6.1.2                      is or becomes
publicly available without fault of the RECEIVING PARTY;

 

6.1.3                      is rightfully
obtained by the RECEIVING PARTY from a third party without restriction as to
disclosure, or is approved for release by written authorization of the
DISCLOSING PARTY;

 

6.1.4                      is developed
independently by the RECEIVING PARTY without use of or access to the DISCLOSING
PARTY’s CONFIDENTIAL INFORMATION.

 

6.2                               PERMITTED USE
AND DISCLOSURE: Each party hereto is permitted to disclose this AGREEMENT and
use or disclose the CONFIDENTIAL INFORMATION disclosed to it by the other
party:

 

6.2.1                      To the extent
such use or disclosure is reasonably necessary in connection with complying
with stock exchange rules.

 

6.2.2                      To its legal
and/or financial advisors, provided such advisors maintain the confidentiality
of this AGREEMENT.

 

6.2.3                      To the extent
such use or disclosure is reasonably necessary to enforce its rights under this
AGREEMENT in connection with a legal proceeding or as required to be disclosed
by law or governmental regulation.

 

6.2.4                      To the extent
such use or disclosure is reasonably necessary in connection with prosecuting
or defending litigation, complying with applicable law, court order, submitting
information to tax or other governmental authorities, or otherwise exercising
its rights hereunder.

 

6.2.5                      In the
instances set forth in Sections 6.2.3 or 6.2.4, the RECEIVING PARTY shall
provide reasonable advance written notice to DISCLOSING PARTY of such
disclosure and reasonably cooperate with the DISCLOSING PARTY in limiting such
disclosure.

 

6.3                               PUBLICITY AND
PRESS RELEASES: Neither party shall issue any press releases relating to this
AGREEMENT without prior written approval of the other party; provided however,
that:

 

6.3.1                      Each party
shall be permitted to post a copy of, provide a link on its web site to or
otherwise summarize any permitted disclosures made under this AGREEMENT;

 

6.3.2                      GTG shall be
able to disclose to other licensees and/or prospective licensees the identity
of LICENSEE and the existence of this AGREEMENT; and

 

6.3.3                      LICENSEE shall
be able to disclose to customers and/or prospective customers the identity of
GTG and the existence of this AGREEMENT.

 

5

 

ARTICLE VII

NOTICE

 

7.1                               Any notice,
request or statement hereunder shall be deemed to be sufficiently given or
rendered when personally delivered, delivered by a major commercial rapid
delivery courier service or mailed by certified or registered mail, return
receipt requested, and if given or rendered to LICENSEE, addressed to:

 

Dennis R. Hoerner

Chief Patent Counsel

Monsanto Company

800 North Lindbergh Blvd.

St. Louis, Missouri 63141-7843

 

or, if given or rendered to
GTG, addressed to:

 

Dr. Mervyn Jacobson

Chief Executive Officer

Genetic Technologies Limited

60 Hanover Street

Fitzroy, Victoria 3065

Australia

Ph: +61 419657915

Fax: + 1 (970) 484-6698

 

with a copy to:

 

Michael A, DeSanctis, Esq.

Hamilton, DeSanctis & Cha,

LLP 225 Union Blvd., Ste. 305

Lakewood, CO 80228

USA

Ph: +1 (303) 284-5103

Fax: + 1 (303) 362-0575

 

or, in any case, to such
changed address or person as GTG or LICENSEE shall have specified to the other
by written notice.

 

ARTICLE VIII

REPRESENTATIONS AND WARRANTIES

 

8.1                               GTG represents
and warrants that it has the full right, power, and authority to enter into and
perform its obligations under this AGREEMENT and grant to LICENSEE the
license and other rights as set forth herein, and there are no outstanding
agreements, grants, licenses, encumbrances, liens, or agreements, either
written or implied, inconsistent therewith or pursuant to which this AGREEMENT
or the parties’ performance hereunder would violate, breach, or cause a
default.

 

6

 

8.2                               GTG represents
and warrants that the execution, delivery, and performance of this AGREEMENT
have been duly authorized by all necessary corporate actions on the part of
GTG.

 

8.3                               LICENSEE
represents and warrants that it has the full right, power, and authority to
enter into and perform its obligations under this AGREEMENT, and there are
no outstanding agreements, grants, licenses, encumbrances, liens, or
agreements, either written or implied, inconsistent therewith or pursuant to
which this AGREEMENT or the parties’ performance hereunder would violate,
breach, or cause a default.

 

8.4                               LICENSEE
represents and warrants that the execution, delivery, and performance of this
AGREEMENT have been duly authorized by all necessary corporate actions on the part of
LICENSEE.

 

8.5                               INDEMNIFICATION:

 

8.5.1                      BY LICENSEE:
LICENSEE agrees to hold GTG harmless from any claims by third parties arising
from the manufacture, use, sale, importation, or other disposition of LICENSED
PRODUCTS by LICENSEE. LICENSEE shall indemnify, hold harmless, and defend GTG,
and GTG’s SUBSIDIARIES, affiliates, officers, directors, representatives,
employees, or agents against any and all claims, causes of action, demands,
judgments, settlements, expenses, or losses including, but not limited to,
reasonable attorneys’ fees and court costs arising out of or in connection
with:  (i) the design, development,
manufacture, use, sale, packaging, distribution, or shipment of LICENSED
PRODUCTS; (ii) any breach by LICENSEE or LICENSEE’s SUBSIDIARIES of any
representation, warranty, or covenant hereunder, or (iii) the failure of
LICENSEE or LICENSEE’s SUBSIDIARIES to perform any covenants or
obligations contained in this AGREEMENT.

 

8.5.2                      BY GTG: GTG
shall indemnify, hold harmless, and defend LICENSEE, and LICENSEE’s
SUBSIDIARIES, affiliates, officers, directors, representatives, employees, or
agents against any and all claims, causes of action, demands, judgments,
settlements, expenses, or losses including, but not limited to, reasonable attorneys’
fees and court costs arising out of or in connection with:  (i) any breach by GTG of any
representation, warranty, or covenant hereunder, or (ii) the failure of
GTG to perform any covenants or obligations contained in this AGREEMENT.

 

8.5.3                      The indemnifying
party’s indemnification obligations under this Section 8.5 are conditioned
upon the indemnified party (i) giving prompt notice of the claim to the
indemnifying party; (ii) granting sale control of the defense or
settlement of the claim or action to the indemnifying party; and (iii) providing
reasonable cooperation to the indemnifying party and, at the indemnifying party’s
request and expense, assistance in the defense or settlement of the claim.

 

7

 

8.6                               DISCLAIMER OF
WARRANTIES:

 

8.6.1                      EXCEPT AS
EXPRESSLY SET FORTH HEREIN, EACH PARTY EXPRESSLY DISCLAIMS, TO THE EXTENT
ALLOWED BY APPLICABLE LAW, ANY AND ALL WARRANTIES OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING WITHOUT LIMITATION THE WARRANTIES OF DESIGN,
MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE (EVEN IF INFORMED OF SUCH
PURPOSE), NONINFRINGEMENT OF THE INTELLECTUAL PROPERTY RIGHTS OF THIRD PARTIES,
OR ARISING FROM A COURSE OF DEALING, USAGE OR TRADE PRACTICES, IN ALL CASES
WITH RESPECT THERETO.

 

8.6.2                      EXCEPT AS
EXPRESSLY SET FORTH HEREIN, LICENSEE AGREES THAT THE LICENSED PATENTS ARE
PROVIDED “AS IS,” AND THAT GTG MAKES NO REPRESENTATION OR WARRANTY WITH RESPECT
TO THE PERFORMANCE OR SALE OF LICENSED PRODUCTS INCLUDING THEIR SAFETY,
EFFECTIVENESS, OR COMMERCIAL VIABILITY NOTWITHSTANDING ANY OTHER PROVISION OF
THIS AGREEMENT, GTG ADDITIONALLY DISCLAIMS ALL OBLIGATIONS AND LIABILITIES FOR
DAMAGES WHICH ARISE OUT OF OR RESULT FROM THE PERFORMANCE OR SALE OF LICENSED
PRODUCTS. LICENSEE ASSUMES ALL RESPONSIBILITY AND LIABILITY FOR LOSS OR DAMAGE
CAUSED BY PERFORMANCE OR SALE OF LICENSED PRODUCTS.

 

8.7                               LIMITATION OF
LIABILITY: EXCEPT FOR LIABILITY FOR BREACH OF ARTICLE VI, NEITHER PARTY
SHALL BE ENTITLED TO RECOVER FROM THE OTHER PARTY ANY SPECIAL, INCIDENTAL,
CONSEQUENTIAL OR PUNITIVE DAMAGES IN CONNECTION WITH THIS AGREEMENT OR ANY
LICENSE GRANTED HEREUNDER.

 

8.8                               Nothing
contained in this AGREEMENT shall be construed as:

 

8.8.1                      a warranty or
representation by GTG as to the validity, enforceability, or scope of any
LICENSED PATENT; or

 

8.8.2                      a warranty or
representation that any manufacture, sale, lease, use or other disposition
hereunder will be free from infringement of patents other than those under
which and to the extent to which licenses are in force hereunder; or

 

8.8.3                      an agreement to
bring or prosecute actions or suits against third parties for infringement or
conferring any right to bring or prosecute actions or suits against third
parties for infringement; or

 

8.8.4                      conferring any
right to use by either party, in advertising, publicity, or otherwise, any
trademark, trade name or name, or any contraction, abbreviation or simulation
thereof, of the other party; or

 

8

 

8.8.5                      conferring by
implication, estoppel or otherwise, upon LICENSEE, any license or other right
under any intellectual property or patent, except that expressly granted
hereunder.

 

ARTICLE IX

MISCELLANEOUS

 

9.1                               NO ASSISTANCE
TO THIRD PARTIES: Except as legally compelled, such as in responding to a
lawfully issued subpoena or other investigative demand, LICENSEE, for itself,
its successors and assigns, will not contest (or knowingly assist another to
contest) the validity or enforceability of the LICENSED PATENTS or GTG’s
ownership interests thereto.

 

9.2                               CONSTRUCTION:
This AGREEMENT has been negotiated by the parties and their respective counsel.
This AGREEMENT shall be interpreted fairly in accordance with its terms and
without any strict construction in favor of or against either party. This
AGREEMENT shall not be construed in favor or against either party by reason of
the authorship of any provisions hereof. The existence or absence of any term
or condition of this AGREEMENT shall not be used in the construction or
interpretation of any other agreement between the parties. The existence or
absence of any term or condition of any other agreement between the parties
shall not be used in the construction or interpretation of this AGREEMENT.

 

9.3                               MARKINGS:
LICENSEE shall use markings as GTG may reasonably request from time to
time, including, but not limited to, marking the LICENSED PRODUCTS and/or
documentation related thereto with patent numbers).

 

9.4                               MODIFICATION:
This AGREEMENT sets forth the entire agreement and understanding between the
parties as to the subject matter of this AGREEMENT and merges all prior
discussions between the parties, and no one of the parties shall be bound by
any modification of this AGREEMENT, or by any conditions, definitions,
warranties, or representations with respect to the subject matter of this
AGREEMENT, other than as expressly provided for herein, or as duly set forth on
or subsequent to the EFFECTIVE DATE in writing and signed by duly authorized
representatives of the party to be bound thereby.

 

9.5                               CHOICE OF LAW:
This AGREEMENT and matters connected with the performance thereof shall be
construed, interpreted, applied and governed in all respects in accordance the
laws of the state of Colorado and of the United States.

 

9.6                               DISPUTE
RESOLUTION:

 

9.6.1                      The parties
agree that, in the event of any difference, dispute or question, arising from
this AGREEMENT, the parties will endeavor to settle such matters amicably
between themselves in good faith. Should the parties be unable to do so within
a period of forty-five (45) working days, the matter shall be promptly
submitted to arbitration in accordance with the rules of the American
Arbitration Association, and judgment upon the award rendered by the
arbitrators may be entered in any 

 

9

 

court in Colorado having
jurisdiction thereof. This arbitration agreement shall not apply to any
controversy or claim involving an issue of the infringement, validity, or
enforceability of any patent. The arbitration shall be governed by the United
States Arbitration Act, 9 U.S.C. §§ 1-16, to the exclusion of any
provisions of state law inconsistent therewith or which would produce a
different result.

 

9.6.2                      A single
arbitrator who is (i) fluent in written and spoken English; and (ii) skilled
and experienced in technology licensing shall be selected by agreement between
the parties. If the parties fail to agree on an arbitrator, a single arbitrator
shall be selected in accordance with the procedures set forth in the
Arbitration Rules. The arbitrator shall render a final award in accordance with
the substantive law of the State of Colorado, excluding the conflicts
provisions of such law.

 

9.6.3                      The arbitrator
shall be fully compensated in accordance with his or her normal hourly or per
diem rates for all time spent in connection with the arbitration proceeding. Pending
a final award, the arbitrator’s compensation and expenses shall be advanced
equally by the parties.

 

9.6.4                      The parties may request
a court for interim or provisional relief, and any such request shall not be
deemed incompatible with the agreement to arbitrate or as a waiver of that
agreement

 

9.6.5                      In no event
will the arbitrator have the power to include any element of punitive damages
or incidental or consequential damages in the arbitration award.

 

9.6.6                      Notwithstanding
the foregoing or anything to the contrary herein, either party may seek
and obtain an injunction or other appropriate relief from a court to preserve
the status quo with respect to any matter pending conclusion of the arbitration
proceeding or to enforce or protect any of its intellectual property rights.

 

9.7                               ATTORNEYS’
FEES: Upon resolution of any claim or controversy arising under this AGREEMENT,
the prevailing party shall be awarded its reasonable attorneys’ fees and costs
in addition to any other amount awarded.

 

9.8                               INDEPENDENT
BUSINESS: The parties acknowledge that their business operations are completely
independent and neither party shall at any time hold itself out as an agent or
representative of the other party. No partnership, joint venture, or other
relationship shall be deemed to exist by virtue of this AGREEMENT.

 

9.9                               INDEPENDENT
TERMS: All the terms of this AGREEMENT shall be independent and unconditional
so that the performance of anyone term shall not be subject to any set off or
counterclaim.

 

9.10                         SEVERABILITY:
In the event any clause or term of this AGREEMENT is determined to be void,
invalid, or unenforceable, the clause shall be reformed to the extent necessary
in order to overcome the limitation and as revised this AGREEMENT shall remain
in full force and effect.

 

10

 

9.11                         HEADINGS: The
headings contained within this AGREEMENT are for convenience and reference
purposes only. They do not form a part hereof and shall not affect
the meaning or interpretation of this AGREEMENT.

 

9.12                         FURTHER
ASSURANCES: The parties hereto shall execute such further documents and perform such
further acts as may be necessary to comply with the terms of this AGREEMENT
and consummate the transactions herein provided.

 

9.13                         FORCE MAJEURE:
Neither party shall be held responsible if the fulfillment of any terms or
provisions of this AGREEMENT are delayed or prevented by wars, revolutions,
fires, floods, acts of God, acts of terrorism whether actual or threatened, or
other causes similar to those enumerated and not within the control of the
party whose performance is interfered with, and which by the exercise of
reasonable diligence, the party is unable to prevent.

 

9.14                         COUNTERPARTS:
This AGREEMENT maybe executed in counterparts (and evidenced by facsimile
signatures), each of which will be deemed an original and all of which together
constitute one instrument.

 

[REMAINDER OF PAGE INTENTIONALLY
LEFT BLANK]

 

11

 

IN WITNESS WHEREOF, the
parties hereto have caused their authorized representatives to execute this
AGREEMENT.

 

 

	
  GTG:

  	
  LICENSEE:

  
	
   

  	
   

  
	
  GENETIC TECHNOLOGIES LIMITED

  	
  MONSANTO COMPANY

  
	
   

  	
   

  
	
   

  	
   

  
	
  By

  	
   

  	
   

  	
  By

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Printed Name / Date

  	
  Printed Name / Date

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Title

  	
  Title

  

 

12

 

APPENDIX “A”

LICENSED PATENTS

 

	
  US Patent No.

  	
   

  	
  Earliest Priority

  Date

  	
   

  	
  Filing Date

  	
   

  	
  Issue Date

  	
   

  	
  Expiration Date

  
	
  5,789,568

  	
   

  	
  8/25/1989

  	
   

  	
  7/16/1996

  	
   

  	
  8/4/1998

  	
   

  	
  8/25/2009

  
	
  5,192,659

  	
   

  	
  8/25/1989

  	
   

  	
  7/11/1990

  	
   

  	
  3/9/1993

  	
   

  	
  3/9/2010

  
	
  5,612,179

  	
   

  	
  8/25/1989

  	
   

  	
  9/23/1992

  	
   

  	
  3/18/1997

  	
   

  	
  3/9/2010

  
	
  5,851,762

  	
   

  	
  7/11/1990

  	
   

  	
  8/22/1994

  	
   

  	
  12/22/1998

  	
   

  	
  12/22/2015

  

 

[REMAINDER OF PAGE INTENTIONALLY
LEFT BLANK]

 

13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}]]